Acquisitions
1 Acquisitions
IPO / Stock
Went Public on Jul 26, 2012 / NASDAQ:HPTX
Headquarters:
South San Francisco, CA
Description:
Hyperion Therapeutics is a biopharmaceutical company focused on creating treatments for urea cycle disorders and other rare diseases.
Founders:
Marl Blumling
Categories:
Health Care, Biotechnology
Website:
http://www.hyperiontx.com

Company Details

Update
Founded:
2006
Contact:
Employees:
8 in CrunchBase

Hyperion is a biotech company developing therapies to address "orphan or underserved patient populations." They are located in South San Francisco, CA.

Funding Rounds (7) - $166M

Update

Investors (6)

Update

Offices/Locations (1)

Update
  • Corporate Headquarters

    601 Gateway Blvd.

    Suite 200

    South San Francisco, CA 94080

    USA

Images (1)

Update
  • 8ade26461b36cf211df25cfb4bc4fa54